Malignant melanoma of the extremities: A clinicopathologic study using levels of invasion (microstage)

A clinicopathologic study was done in 151 patients with malignant melanoma of the extremities who were surgically treated in Memorial Hospital and had 5– to 9‐year followup. Microstaging was done according to the depth of invasion, as determined by Clark's levels as well as by direct measurement. This was related to treatment and to clinical course. There was a correlation between the depth of invasion by Clark's levels and the incidence of lymph node metastases in patients with Stage I melanoma who had elective node dissection. The incidence of nodal metastases was 4% for Level II, 7% for Level III, 25% for Level IV, and 70% for Level V. There was a correlation between Clark's level of invasion and survival after surgery. The 5‐year cure rate was 100% for Level II, 88% for Level III, 60% for Level IV, and 15% for Level V melanoma. The presence of nodal metastases augured a much worse prognosis than Clark's level per se. In patients with Level IV melanoma, the 5‐year cure rate was 82% in patients with negative nodes and 27% in those with nodal metastases after elective node dissection. Microstaging primary melanoma according to Clark's levels serves as a useful standard with which to compare surgical results. In this series of extremity melanomas there was no difference between local recurrence and lymphadenectomy for Level II melanoma. For Level III and Level IV melanoma, wide excision and lymphadenectomy gave higher cure rates than wide excision only, both at 5 and 9 years after surgery. The results were significant only for patients with Level III, however. Use of the measured depth of invasion added significant clinicopathologic information. The incidence of nodal metastases at elective node dissection was 5 to 9% for melanoma showing 0.6 to 2.0 mm of invasion, 22% for melanoma measuring 2.1 to 3.0 mm, and 39% for melanoma invading beyond 3.0 mm. The 5‐year cure rate was 100% for melanoma measuring less than 1.0 mm, 83% for melanoma invading 1.1 to 2.0 mm, 58% for lesions measuring 2.1 to 3.0 mm, and 55% for melanoma invading over 3.0 mm. The microstage technique combining Clark's levels and the measured depth of invasion has an important use as a prognostic index and as a standard upon which to select treatment for primary melanoma of the extremities.

[1]  A. Dellon,et al.  Surgical treatment of stage I melanoma. , 1973, Archives of surgery.

[2]  E. Strong,et al.  Prognostic factors in cutaneous melanoma of the head and neck. , 1973, The American journal of pathology.

[3]  A Breslow,et al.  Thickness, Cross‐Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma , 1970, Annals of surgery.

[4]  J. Shah,et al.  Prognostic significance of lymph node dissection in the treatment of malignant melanoma , 1970, Cancer.

[5]  V. McGovern The Classification of Melanoma and its Relationship with Prognosis , 1970, Pathology.

[6]  W. Clark,et al.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin. , 1969, Cancer research.

[7]  J. Mehnert,et al.  STAGING OF MALIGNANT MELANOMAS BY DEPTH OF INVASION; A PROPOSED INDEX TO PROGNOSIS. , 1965, American journal of surgery.

[8]  G. Mcneer,et al.  LIFE HISTORY OF MELANOMA. , 1965, The American journal of roentgenology, radium therapy, and nuclear medicine.

[9]  J. Fortner,et al.  RESULTS OF GROIN DISSECTION FOR MALIGNANT MELANOMA IN 220 PATIENTS. , 1964, Surgery.

[10]  W. E. Price,et al.  REGIONAL LYMPH NODE DISSECTION AND MALIGNANT MELANOMA. EFFECT OF SURVIVAL. , 1963, Archives of surgery.

[11]  L. W. Guiss,et al.  The role of radical regional lymphadenectomy in treatment of melanoma , 1962 .

[12]  N. Petersen,et al.  Malignant melanomas of the skin. A study of the origin, development, aetiology, spread, treatment, and prognosis. I. , 1962, British journal of plastic surgery.

[13]  James K. Malm,et al.  Clinicopathological correlations in a series of 117 malignant melanomas of the skin of adults , 1958, Cancer.

[14]  R. Lund,et al.  Malignant melanoma; clinical and pathologic analysis of 93 cases. Is prophylactic lymph node dissection indicated? , 1955, Surgery.

[15]  A. Allen,et al.  Malignant melanoma. A clinicopathological analysis of the criteria for diagnosis and prognosis , 1953, Cancer.